BridgeBio Pharma (BBIO) Payables (2018 - 2026)
BridgeBio Pharma (BBIO) recorded Payables of $88.26 million in Q3 2026, up 371.9% from $18.7 million a year earlier and up 224.5% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma reported Payables of $36.23 million, up 276.7% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
- Across earlier years, Payables came in at $9.62 million in FY2024 (-9.7%), $10.66 million in FY2023 (-7.8%), $11.56 million in FY2022 (-2.7%) and $11.88 million in FY2021 (+32.9%).
- The Q3 2026 figure is the highest quarterly Payables in data going back to Q4 2018.
- On a year-over-year basis, Payables has increased for seven consecutive quarters, with growth averaging 151.9% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 482.2% in Q1 2025, against a decline of 60.6% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $27.2 million (Q2 2026), $29.06 million (Q1 2026) and $36.23 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | 88.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.26 Mn |
| Jun 30, 2026 | 27.20 Mn |
| Mar 31, 2026 | 29.06 Mn |
| Dec 31, 2025 | 36.23 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 26.13 Mn |
| Mar 31, 2025 | 27.53 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 13.36 Mn |
| Jun 30, 2024 | 18.13 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 10.16 Mn |
| Jun 30, 2022 | 8.79 Mn |
| Mar 31, 2022 | 10.11 Mn |
| Dec 31, 2021 | 11.88 Mn |
API Access
BridgeBio Pharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();